STK11 and non-small cell lung carcinoma: Analysis of the AACR project GENIE data set (v15.1) via cBioPortal shows genetic alterations of LKB1 in 3% of 160,994 cancer samples, of which the greatest prevalence of alterations is observed in non-small cell lung cancer (NSCLC) (13.46%), parathyroid cancer (11.76%), cervical cancer (8.64%), anal cancer (8.43%) and adrenocortical adenoma (6.9%) (Figure 1).